Literature DB >> 32002772

Effects of Peroxiredoxin 2 in Neurological Disorders: A Review of its Molecular Mechanisms.

Jifei Liu1, Gang Su2, Juan Gao1, Ye Tian1, Xiaoyan Liu1, Zhenchang Zhang3.   

Abstract

Oxidative stress and neuroinflammation are closely related to the pathological processes of neurological disorders. Peroxiredoxin 2 (Prdx2) is an abundant antioxidant enzyme in the central nervous system. Prdx2 reduces the production of reactive oxygen species and participates in regulating various signaling pathways in neurons by catalyzing hydrogen peroxide (H2O2), thereby protecting neurons against oxidative stress and an inflammatory injury. However, the spillage of Prdx2, as damage-associated molecular patterns, accelerates brain damage after stroke by activating an inflammatory response. The post-translational modifications of Prdx2 also affect its enzyme activity. This review focuses on the effects of Prdx2 and its molecular mechanisms in various neurological disorders.

Entities:  

Keywords:  Neuroinflammation; Neurological disorders; Neuroprotection; Oxidative stress; Peroxiredoxin 2

Year:  2020        PMID: 32002772     DOI: 10.1007/s11064-020-02971-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  76 in total

1.  Neuroprotective effect of PEP-1-peroxiredoxin2 on CA1 regions in the hippocampus against ischemic insult.

Authors:  Hoon Jae Jeong; Dae Young Yoo; Dae Won Kim; Hyeon Ji Yeo; Su Bin Cho; Jiye Hyeon; Jung Hwan Park; Jinseu Park; Won Sik Eum; Hyun Sook Hwang; Moo-Ho Won; In Koo Hwang; Soo Young Choi
Journal:  Biochim Biophys Acta       Date:  2014-03-12

2.  Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene.

Authors:  Shuchi Agrawal-Singh; Fabienne Isken; Konstantin Agelopoulos; Hans-Ulrich Klein; Nils H Thoennissen; Gabriele Koehler; Antje Hascher; Nicole Bäumer; Wolfgang E Berdel; Christian Thiede; Gerhard Ehninger; Anke Becker; Peter Schlenke; Yipeng Wang; Michael McClelland; Utz Krug; Steffen Koschmieder; Thomas Büchner; Dae-Yeul Yu; Shailendra Vikram Singh; Klaus Hansen; Hubert Serve; Martin Dugas; Carsten Müller-Tidow
Journal:  Blood       Date:  2011-12-29       Impact factor: 22.113

3.  Obovatol attenuates microglia-mediated neuroinflammation by modulating redox regulation.

Authors:  Jiyeon Ock; Hyung S Han; Su H Hong; So Y Lee; Young-Min Han; Byoung-Mog Kwon; Kyoungho Suk
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

4.  Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain.

Authors:  Takashi Shichita; Eiichi Hasegawa; Akihiro Kimura; Rimpei Morita; Ryota Sakaguchi; Ichiro Takada; Takashi Sekiya; Hiroaki Ooboshi; Takanari Kitazono; Toru Yanagawa; Tetsuro Ishii; Hideo Takahashi; Shuji Mori; Masahiro Nishibori; Kazumichi Kuroda; Shizuo Akira; Kensuke Miyake; Akihiko Yoshimura
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

5.  Combinatorial Preconditioning of Rat Brain Cultures with Subprotective Ethanol and Resveratrol Concentrations Promotes Synergistic Neuroprotection.

Authors:  N Khodaie; N Tajuddin; R M Mitchell; E J Neafsey; M A Collins
Journal:  Neurotox Res       Date:  2018-03-12       Impact factor: 3.911

6.  Probucol and atorvastatin in combination protect rat brains in MCAO model: upregulating Peroxiredoxin2, Foxo3a and Nrf2 expression.

Authors:  Yuanyuan Du; Xiangjian Zhang; Hui Ji; Haichao Liu; Shuya Li; Litao Li
Journal:  Neurosci Lett       Date:  2012-01-05       Impact factor: 3.046

7.  Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome.

Authors:  S H Kim; M Fountoulakis; N Cairns; G Lubec
Journal:  J Neural Transm Suppl       Date:  2001

8.  Proteomic analysis of focal cerebral ischemic injury in male rats.

Authors:  Phil-Ok Koh
Journal:  J Vet Med Sci       Date:  2009-11-27       Impact factor: 1.267

9.  Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease.

Authors:  Dianbo Qu; Juliet Rashidian; Matthew P Mount; Hossein Aleyasin; Mohammad Parsanejad; Arman Lira; Emdadul Haque; Yi Zhang; Steve Callaghan; Mireille Daigle; Maxime W C Rousseaux; Ruth S Slack; Paul R Albert; Inez Vincent; John M Woulfe; David S Park
Journal:  Neuron       Date:  2007-07-05       Impact factor: 17.173

Review 10.  The Roles of Thrombospondins in Hemorrhagic Stroke.

Authors:  Xuan Wu; Xu Luo; Qiquan Zhu; Jie Zhang; Yun Liu; Hansheng Luo; Yuan Cheng; Zongyi Xie
Journal:  Biomed Res Int       Date:  2017-10-30       Impact factor: 3.411

View more
  5 in total

1.  Chetomin rescues pathogenic phenotype of LRRK2 mutation in drosophila.

Authors:  Ling Ling Chua; Patrick Ho; Joanne Toh; Eng-King Tan
Journal:  Aging (Albany NY)       Date:  2020-09-24       Impact factor: 5.955

2.  Altered Expression of Peroxiredoxins in Mouse Model of Progressive Myoclonus Epilepsy upon LPS-Induced Neuroinflammation.

Authors:  Mojca Trstenjak Prebanda; Petra Matjan-Štefin; Boris Turk; Nataša Kopitar-Jerala
Journal:  Antioxidants (Basel)       Date:  2021-02-27

Review 3.  Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update.

Authors:  Roohi Mohi-Ud-Din; Reyaz Hassan Mir; Abdul Jalil Shah; Saba Sabreen; Taha Umair Wani; Mubashir Hussain Masoodi; Esra Küpeli Akkol; Zulfiqar Ali Bhat; Haroon Khan
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

4.  CRISPR-Mediated Induction of Neuron-Enriched Mitochondrial Proteins Boosts Direct Glia-to-Neuron Conversion.

Authors:  Gianluca L Russo; Giovanna Sonsalla; Poornemaa Natarajan; Christopher T Breunig; Giorgia Bulli; Juliane Merl-Pham; Sabine Schmitt; Jessica Giehrl-Schwab; Florian Giesert; Martin Jastroch; Hans Zischka; Wolfgang Wurst; Stefan H Stricker; Stefanie M Hauck; Giacomo Masserdotti; Magdalena Götz
Journal:  Cell Stem Cell       Date:  2020-11-16       Impact factor: 24.633

5.  SepA Enhances Shigella Invasion of Epithelial Cells by Degrading Alpha-1 Antitrypsin and Producing a Neutrophil Chemoattractant.

Authors:  Mario Meza-Segura; James R Birtley; Ana Maldonado-Contreras; Christian Mueller; Karl J Simin; Lawrence J Stern; Beth A McCormick
Journal:  mBio       Date:  2021-11-02       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.